欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/4013/002
药品名称Tadalafil-ratiopharm 5 mg Filmtabletten
活性成分
    • tadalafil 5.0 mg
剂型Film-coated tablet
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Tadalafil-ratiopharm 5 mg Filmtabletten
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Tadalafil Teva 5 mg filmomhulde tabletten
    • Netherlands (NL)
      Tadalafil Teva 5 mg filmomhulde tabletten
    • Luxembourg (LU)
      Taladafil-ratiopharm, 5 mg, Comprimé pelliculé
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Tadalafil ratiopharm 5 mg Filmtabletten
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Tadalafil Teva
    • Czechia (CZ)
      TADALAFIL TEVA 5 MG
    • Croatia (HR)
      Tadalafil Pliva 5 mg filmom obložene tablete
    • Hungary (HU)
许可日期2015/04/29
最近更新日期2024/02/28
药物ATC编码
    • G04BE08 tadalafil
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase